Boston Pharmaceuticals Is A Clinical Stage Biopharmaceutical Company Based In Cambridgemassachusettsfounded In 2015The Company Focuses On Developing Therapies For Serious Liver Diseases By Acquiring And Transforming Innovative Molecules Into Differentiated Medicinesit Operates With A Data Driven Drug Development Engineutilizing Expertise In Translational Medicine And Clinical Development To Create Patient Centric Therapies The Company S Lead Investigational Product Is Efimosfermin Alfabos 580 A Long Acting Fibroblast Growth Factor 21 Analogue Currently In A Phase 2 Clinical Trial For Metabolic Dysfunction Associated Steatohepatitisboston Pharmaceuticals Emphasizes A Disciplinedscience Driven Approach To Drug Developmentprioritizing Therapeutic Differentiation And Collaborating With Top Development Organizations To Enhance Its Pipelinethe Company Is Committed To Addressing Unmet Medical Needs In Liver Diseases And Values Its Partnerships With Healthcare Providers And Investorsrecognized As A Great Place To Workboston Pharmaceuticals Fosters A Culture Of Innovationurgencyand Teamworkseeking Professionals Who Are Passionate About Advancing Healthcare Solutions
